Services
Expertises
Resources
Who we are
Closed

Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)

Archived vaccine research leadership initiative

Funding available
$ 300,000
Deadline
Unspecified
Location
Canada
Who can apply
Canadian mid-career researchers
See full eligibility

Overview

Archived CIHR operating grant for Canadian mid-career researchers in vaccinology, offering up to CAD 100,000 per year for up to 3 years. It supports research on epidemic-potential infectious diseases and projects linked to CEPI or the National Research Council of Canada.

At a glance

Funding available

Maximum funding
$300,000
Financing goals
  • Develop strategic partnerships
  • Develop team skills
  • Conduct research and development activities
  • Develop workforce skills
  • Conduct research or evaluation activities

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
  • Youth (<40)
Legal structures
All legal structures

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2026
Periods: 2

Latest changes

Webinar and application details updated

The grant page adds a new upcoming webinar entry and updates webinar links and question-submission details, while the funding rules remain unchanged.

See more

The grant page now includes a new upcoming webinar entry with its date, time, and join link, and it also updates webinar question-submission details with Slido and related links. The core funding description, amounts, and eligibility position appear unchanged, but the added event information and updated support links affect how applicants prepare and access the program.

Eligibility

Who is eligible?

  • Canadian mid-career researchers
  • University-affiliated researchers
  • Applicants working with CEPI
  • Applicants working with NRC

Who is not eligible

  • Former recipients of this CIHR-CEPI vaccine leadership award
  • Researchers whose primary role is outside Canada
  • Applicants unable to secure CEPI or NRC as a partner

Eligible expenses

  • Personnel and trainee costs
  • Supplies, materials, and consumables
  • Travel related to the project
  • Subawardee or subcontractor costs
  • Knowledge mobilization and open access publishing costs

Eligible geographic areas

  • Canada
  • Canadian postsecondary institutions and affiliated institutions

Activities funded

  • Vaccine research and development projects
  • Organ-on-chip platforms for vaccine testing
  • Bioprocess innovation for vaccine production
  • Preclinical, clinical, diagnostic, immunology, AI, or bioinformatics vaccine research

How to apply

  • Step 1: Expression of Interest
    • Log in to ResearchNet.
    • Identify participants and complete required profiles.
    • Submit the EOI summary and select CEPI or NRC.
  • Step 2: Full Application
    • Co-develop the application with the selected partner.
    • Complete the research proposal and budget justification.
    • Upload CVs, SGBA certificates, partner documents, and attestations if required.
  • Step 3: Submit in ResearchNet
    • Upload signature pages and all required attachments.
    • Submit the completed application before the deadline.

Documents Needed

  • Tri-agency CV for all required participants
  • SGBA training certificate
  • Partner conflict of interest document
  • Partner letter of support
  • Signed signature pages

Selection criteria

  • Clarity and strength of the research proposal
  • Quality of the collaboration with the selected partner
  • Feasibility of the proposed research
  • Applicant’s scientific contributions and expertise
  • Expected research impact and knowledge mobilization

Processing and Agreement

  • Applications are first reviewed for relevance at the Expression of Interest stage.
  • Only EOI-selected applicants may submit a Full Application.
  • Full Applications are then reviewed again for relevance and peer review, if applicable.
  • Funding decisions are made from the top-ranked applications.
  • Successful applicants are published on the CIHR website.

Additional information

  • Applicants must choose one applicant partner: CEPI or NRC.
  • The funding opportunity uses a two-step process: Expression of Interest and Full Application.
  • A tri-agency CV is required for all participants except collaborators and sponsors.
  • SGBA training certificates and a partner COI document are mandatory attachments.

Contacts

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) Program

What is the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)?

Archived CIHR operating grant for Canadian mid-career researchers in vaccinology, offering up to CAD 100,000 per year for up to 3 years. It supports research on epidemic-potential infectious diseases and projects linked to CEPI or the National Research Council of Canada.

How much funding can be received?

Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) Funds up to $300,000 of admissible expenses.

Who is eligible for the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) program?

To be eligible for the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) program, you must: The applicant must be a mid-career independent researcher. The applicant must have a Canadian institutional affiliation and a primary role in Canada. The application must include CEPI or the National Research Council of Canada as the partner candidate.

What expenses are eligible under Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)?

Personnel and trainee costs Supplies, materials, and consumables Travel related to the project Subawardee or subcontractor costs Knowledge mobilization and open access publishing costs

Who can I contact for more information about the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025)?

You can contact Canadian Institutes of Health Research (CIHR) by email at support-soutien@cihr-irsc.gc.ca or by phone at 613-954-1968.

Where is the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) available?

The Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) program is available across Canada.

Is the Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) a grant, loan, or tax credit?

Leadership Award for Excellence in Vaccine Research for Infectious Diseases of Epidemic Potential (2025) is a Grant and Funding